Related Articles for PubMed (Select 12184809)

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration.

Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA, Klein HG, Marincola FM.

Genome Biol. 2002 Jun 25;3(7):RESEARCH0035. Epub 2002 Jun 25.

PMID: 12184809 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Mechanism of immune response during immunotherapy.

Panelli MC, Nagorsen D, Wang E, Monsurro V, Jin P, Katia Z, Smith K, Ngalame Y, Marincola FM.

Yonsei Med J. 2004 Jun 30;45 Suppl:15-7.

PMID: 15250044 [PubMed - indexed for MEDLINE]

Genome wide expression profiling of human peripheral blood mononuclear cells stimulated with BAY 50-4798, a novel T cell selective interleukin-2 analog.

Steppan S, Kupfer K, Mayer A, Evans M, Yamasaki G, Greve JM, Eckart MR, Cassell DJ.

J Immunother. 2007 Feb-Mar;30(2):150-68.

PMID: 17471163 [PubMed - indexed for MEDLINE]

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE 3rd.

Clin Cancer Res. 2006 Oct 1;12(19):5850-8.

PMID: 17020993 [PubMed - indexed for MEDLINE]

Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).

Asemissen AM, Scheibenbogen C, Letsch A, Hellstrand K, Thorén F, Gehlsen K, Schmittel A, Thiel E, Keilholz U.

Clin Cancer Res. 2005 Jan 1;11(1):290-7.

PMID: 15671558 [PubMed - indexed for MEDLINE]

A genomic- and proteomic-based hypothesis on the eclectic effects of systemic interleukin-2 administration in the context of melanoma-specific immunization.

Panelli MC, Martin B, Nagorsen D, Wang E, Smith K, Monsurro V, Marincola FM.

Cells Tissues Organs. 2004;177(3):124-31.

PMID: 15388986 [PubMed - indexed for MEDLINE]

The role of interleukin 1 in growth and metastasis of human cancer xenografts.

Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR.

Clin Cancer Res. 2006 Feb 15;12(4):1088-96.

PMID: 16489061 [PubMed - indexed for MEDLINE]

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF.

Cancer Immunol Immunother. 2006 Oct;55(10):1185-97. Epub 2006 Feb 9.

PMID: 16468035 [PubMed - indexed for MEDLINE]

Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.

Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K.

Arthritis Rheum. 2004 Feb;50(2):432-43.

PMID: 14872485 [PubMed - indexed for MEDLINE]

10:

Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma.

del Olmo M, Alonso-Varona A, Castro B, Bilbao P, Palomares T.

Cancer Immunol Immunother. 2006 Aug;55(8):948-57. Epub 2005 Oct 12.

PMID: 16220324 [PubMed - indexed for MEDLINE]

11:

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K, Dressman HK, Jelinek J, Issa JP.

Clin Cancer Res. 2006 Aug 1;12(15):4619-27.

PMID: 16899610 [PubMed - indexed for MEDLINE]

12:

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.

Andersen MH, Gehl J, Reker S, Pedersen LØ, Becker JC, Geertsen P, thor Straten P.

Semin Cancer Biol. 2003 Dec;13(6):449-59. Review.

PMID: 15001164 [PubMed - indexed for MEDLINE]

13:

Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.

Staege MS, Hansen G, Baersch G, Burdach S.

Pediatr Blood Cancer. 2004 Jul;43(1):23-34.

PMID: 15170886 [PubMed - indexed for MEDLINE]

14:

Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.

Kijima M, Saio M, Oyang GF, Suwa T, Miyauchi R, Kojima Y, Imai H, Nakagawa J, Nonaka K, Umemura N, Nishimura T, Takami T.

Int J Oncol. 2005 Mar;26(3):679-84.

PMID: 15703823 [PubMed - indexed for MEDLINE]

15:

Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets.

Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P.

Circulation. 2003 Jun 3;107(21):2670-6. Epub 2003 May 12.

PMID: 12742982 [PubMed - indexed for MEDLINE]

16:

Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.

Wack C, Kirst A, Becker JC, Lutz WK, Bröcker EB, Fischer WH.

Cancer Immunol Immunother. 2002 Oct;51(8):431-9. Epub 2002 Jul 25.

PMID: 12202904 [PubMed - indexed for MEDLINE]

17:

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.

Shanafelt AB, Lin Y, Shanafelt MC, Forte CP, Dubois-Stringfellow N, Carter C, Gibbons JA, Cheng SL, Delaria KA, Fleischer R, Greve JM, Gundel R, Harris K, Kelly R, Koh B, Li Y, Lantz L, Mak P, Neyer L, Plym MJ, Roczniak S, Serban D, Thrift J, Tsuchiyama L, Wetzel M, Wong M, Zolotorev A.

Nat Biotechnol. 2000 Nov;18(11):1197-202.

PMID: 11062441 [PubMed - indexed for MEDLINE]

18:

Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.

Zeng Y, Huebener N, Fest S, Weixler S, Schroeder U, Gaedicke G, Xiang R, Schramm A, Eggert A, Reisfeld RA, Lode HN.

Cancer Res. 2007 Mar 1;67(5):2331-8.

PMID: 17332365 [PubMed - indexed for MEDLINE]

19:

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.

Switaj T, Jalili A, Jakubowska AB, Drela N, Stoksik M, Nowis D, Basak G, Golab J, Wysocki PJ, Mackiewicz A, Sasor A, Socha K, Jakóbisiak M, Lasek W.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4165-75.

PMID: 15217954 [PubMed - indexed for MEDLINE]

20:

A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.

Parihar R, Nadella P, Lewis A, Jensen R, De Hoff C, Dierksheide JE, VanBuskirk AM, Magro CM, Young DC, Shapiro CL, Carson WE 3rd.

Clin Cancer Res. 2004 Aug 1;10(15):5027-37.

PMID: 15297404 [PubMed - indexed for MEDLINE]

Recent Activity